AmerisourceBergen 2014 Annual Report Download - page 16

Download and view the complete annual report

Please find page 16 of the 2014 AmerisourceBergen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 28

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28

AmerisourceBergens primary
responsibility as a public company
is to increase shareholder value and
provide for the long-term success of
the Company. In pursuit of that goal,
we run our business ethically and in
a transparent manner, we value and
respect the many contributions of
our diverse base of associates, and we
promote the interests of, and collaborate
with our business partners. Our
corporate citizenship is grounded
in our consistent financial success,
which is driven by our associates’
commitment to financial stewardship
and operational excellence.
We focus our efforts on
continuously improving the safety,
efficiency, and productivity of our
operations and the pharmaceutical
supply channel, and helping ensure
patients have access to medications.
To accomplish this, we purchase
pharmaceuticals for distribution in
the U.S. directly from the products
manufacturers, or their authorized
representatives. In addition, we use
sophisticated order monitoring systems
and state-of-the-art programs to
manage product placement in our
warehouses, both engineered to
enhance the security of the supply
chain, and to help associates fill
customer orders efficiently and with
a near-perfect accuracy rate. We have
a solid track record of regulatory
compliance, and we work with
regulatory authorities in the countries
we serve to facilitate responses to
changing regulations and market
dynamics, and to build awareness
about the important role we play
in the provision of healthcare in the
U.S. and abroad.
Corporate Governance
AmerisourceBergen management
works closely with our Board of Directors
to facilitate their understanding of our
business and our strategic objectives,
and to ensure that the interests of
management and the Board are
aligned with stockholder interests.
AmerisourceBergen routinely reviews
its corporate governance principles,
the Board Committee charters, codes
of conduct, and other governance
policies to ensure that they remain
timely and effective. The Company
requires that all associates participate
in ongoing compliance and ethics
training, and promotes active
communication and engagement
across all business levels. We provide
and promote equal opportunities for
professional growth and development
while respecting and recognizing the
value of the different perspectives our
associates bring to our organization.
AmerisourceBergen offers a competitive
benefits package to all associates
on a non-discriminatory basis which
includes healthcare insurance, paid
time off, the opportunity to participate
in the Company’s 401(k) plan,
educational opportunities and tuition
reimbursement, and other benefits.
AmerisourceBergen participates
in the U.S. political process to advance
the interests of the Company and
our associates by making political
contributions, by lobbying legislators
and other government officials, and by
working with industry and trade groups
at both the national and state level.
In these efforts, we focus on healthcare
policy issues that directly affect our
business and the businesses of our
customers, including the enactment
of laws and regulations intended to
protect the safety of the pharmaceutical
supply chain and implementation of
healthcare reform under the Patient
Protection and Affordable Care Act.
We are committed to participating
responsibly and ethically in the political
process, and we disclose our aggregate
expenditures for political contributions
and lobbying activities on an annual
basis. The conduct we require of our
directors, officers and employees in
their interactions with government
officials is reflected in the Companys
Code of Ethics and Business Conduct.
Sustainability
Our ability to continuously
improve efficiency is a core competency
and a key way in which we continue to
deliver value to our stakeholders. We
actively encourage our associates at all
levels of our business to discover and
implement new ways to sustainably
grow our business, and to do so in
ways that enrich and improve the
communities we serve.
The Company actively seeks ways
to reduce costs and energy consumption
while improving the safety, efficiency
and speed of our operations and the
entire pharmaceutical supply channel.
In our daily operations, we ship
pharmaceuticals in reusable plastic
totes and cold packs, and recycle
cardboard, Styrofoam, and other
materials across our distribution
network. We consolidate orders and
shipments and utilize sophisticated
delivery route planning software
14
Corporate and Social Responsibility